Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Tenon Medical (TNON) EBITDA Margin (2021 - 2025)

Historic EBITDA Margin for Tenon Medical (TNON) over the last 5 years, with Q3 2025 value amounting to 284.65%.

  • Tenon Medical's EBITDA Margin rose 743100.0% to 284.65% in Q3 2025 from the same period last year, while for Sep 2025 it was 396.26%, marking a year-over-year increase of 145400.0%. This contributed to the annual value of 415.84% for FY2024, which is 1144600.0% up from last year.
  • Per Tenon Medical's latest filing, its EBITDA Margin stood at 284.65% for Q3 2025, which was up 743100.0% from 490.96% recorded in Q2 2025.
  • Over the past 5 years, Tenon Medical's EBITDA Margin peaked at 284.65% during Q3 2025, and registered a low of 7613.64% during Q2 2021.
  • Its 5-year average for EBITDA Margin is 1834.01%, with a median of 574.56% in 2023.
  • Per our database at Business Quant, Tenon Medical's EBITDA Margin crashed by -19740800bps in 2022 and then surged by 35261800bps in 2023.
  • Over the past 5 years, Tenon Medical's EBITDA Margin (Quarter) stood at 5362.26% in 2021, then soared by 47bps to 2829.24% in 2022, then surged by 87bps to 380.94% in 2023, then decreased by -5bps to 400.91% in 2024, then grew by 29bps to 284.65% in 2025.
  • Its EBITDA Margin stands at 284.65% for Q3 2025, versus 490.96% for Q2 2025 and 498.07% for Q1 2025.